Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Long-Term Investments (2022 - 2025)

Q32 Bio (QTTB) has 4 years of Long-Term Investments data on record, last reported at $2.5 million in Q1 2025.

  • For Q1 2025, Long-Term Investments fell 46.53% year-over-year to $2.5 million; the TTM value through Mar 2025 reached $2.5 million, down 46.53%, while the annual FY2024 figure was $2.6 million, N/A changed from the prior year.
  • Long-Term Investments reached $2.5 million in Q1 2025 per QTTB's latest filing, down from $2.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $30.6 million in Q1 2022 and bottomed at $2.5 million in Q1 2025.
  • Average Long-Term Investments over 4 years is $15.2 million, with a median of $15.6 million recorded in 2023.
  • Peak YoY movement for Long-Term Investments: fell 24.81% in 2023, then tumbled 81.37% in 2024.
  • A 4-year view of Long-Term Investments shows it stood at $25.8 million in 2022, then crashed by 45.93% to $14.0 million in 2023, then crashed by 81.37% to $2.6 million in 2024, then dropped by 2.85% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $2.5 million in Q1 2025, $2.6 million in Q4 2024, and $2.6 million in Q3 2024.